Details for: PPP1R12A
Gene ID: 4659
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: PPP1R12A
Ensembl ID: ENSG00000058272
Description: protein phosphatase 1 regulatory subunit 12A
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 45.12rCSI 75.74%PRS 8.46
-
CSI 39.85rCSI 96.84%PRS 8.23
-
CSI 39.06rCSI 70.97%PRS 11.65
-
CSI 38.58rCSI 55.05%PRS 16.12
-
CSI 34.94rCSI 75.8%PRS 8.29
-
CSI 33.68rCSI 74.11%PRS 8.57
-
CSI 33.29rCSI 84.22%PRS 17.79
-
CSI 31.02rCSI 73.98%PRS 41.33
-
CSI 29.64rCSI 92.63%PRS 9.01
-
CSI 28.34rCSI 45.58%PRS 9.23
-
CSI 26.96rCSI 97.02%PRS 7.86
-
CSI 26.82rCSI 77.66%PRS 16.23
-
CSI 26.76rCSI 33.29%PRS 7.85
-
CSI 26.46rCSI 36.17%PRS 16.23
-
CSI 24.62rCSI 58.89%PRS 8.15
-
CSI 23.77rCSI 78.11%PRS 7.75
-
CSI 23.68rCSI 65.25%PRS 13.34
-
CSI 23.46rCSI 88.68%PRS 8.62
-
CSI 21.09rCSI 27.19%PRS 8.87
-
CSI 21.03rCSI 55.99%PRS 11.4
-
CSI 20.39rCSI 38.5%PRS 17.8
-
CSI 20.32rCSI 65.9%PRS 17.48
-
CSI 17.47rCSI 38.6%PRS 10.28
-
CSI 16.51rCSI 14.91%PRS 12.71
-
CSI 16.34rCSI 19.52%PRS 8.25
-
CSI 15.9rCSI 28.09%PRS 8.39
-
CSI 15.86rCSI 93.37%PRS 8.86
-
CSI 15.17rCSI 47.46%PRS 9.66
-
CSI 15.03rCSI 74.1%PRS 19.39
-
CSI 14.63rCSI 17.19%PRS 16.81
-
CSI 12.34rCSI 33.92%PRS 23.62
-
CSI 11.43rCSI 83.98%PRS 7.6
-
CSI 11.19rCSI 31.95%PRS 24.54
-
CSI 10.74rCSI 8.28%PRS 13.02
-
CSI 10.38rCSI 35.56%PRS 12.51
-
CSI 10.27rCSI 53.99%PRS 25.42
-
CSI 9.38rCSI 31.77%PRS 12.67
-
CSI 9.25rCSI 20.75%PRS 8.81
-
CSI 9.12rCSI 29.27%PRS 20.74
-
CSI 8.92rCSI 23.19%PRS 18.84
-
CSI 8.51rCSI 34.7%PRS 19.07
-
CSI 8.42rCSI 17.81%PRS 28.92
-
CSI 8.26rCSI 41.05%PRS 15.26
-
CSI 8.17rCSI 11.32%PRS 20.52
-
CSI 8.08rCSI 14.16%PRS 10.59
-
CSI 7.64rCSI 10.97%PRS 11.09
-
CSI 7.58rCSI 16.6%PRS 19.07
-
CSI 7.23rCSI 23.27%PRS 15.18
-
CSI 6.88rCSI 11.89%PRS 10.89
-
CSI 6.81rCSI 13.99%PRS 14.37
-
CSI 6.41rCSI 9.28%PRS 21.13
-
CSI 6.4rCSI 17.04%PRS 36.36
-
CSI 6.01rCSI 16.06%PRS 11.97
-
CSI 5.8rCSI 17.88%PRS 21.64
-
CSI 5.73rCSI 4.82%PRS 23
-
CSI 5.31rCSI 45.77%PRS 5.24
-
CSI 5.17rCSI 77.52%PRS 43.5
-
CSI 5.15rCSI 23.81%PRS 29.6
-
CSI 5.11rCSI 8.17%PRS 15.67
-
CSI 4.98rCSI 3.93%PRS 9.85
-
CSI 4.87rCSI 25.16%PRS 27.87
-
CSI 4.6rCSI 29.45%PRS 21.33
-
CSI 4.34rCSI 11.23%PRS 13.36
-
CSI 4.25rCSI 34.55%PRS 14.74
-
CSI 4.25rCSI 10.21%PRS 21.43
-
CSI 4.24rCSI 60.11%PRS 10.2
-
CSI 4.03rCSI 2.68%PRS 17.12
-
CSI 3.96rCSI 9.93%PRS 40.62
-
CSI 3.82rCSI 77.68%PRS 11.96
-
CSI 3.81rCSI 77.53%PRS 10.97
-
CSI 3.8rCSI 44.06%PRS 52.15
-
CSI 3.74rCSI 5.64%PRS 14.17
-
CSI 3.73rCSI 89.93%PRS 7.58
-
CSI 3.7rCSI 3.69%PRS 12.22
-
CSI 3.61rCSI 5.21%PRS 19.91
-
CSI 3.56rCSI 8.69%PRS 14.19
-
CSI 3.47rCSI 54.77%PRS 8.52
-
CSI 3.45rCSI 26.47%PRS 47.68
-
CSI 3.4rCSI 2.75%PRS 22.91
-
CSI 3.4rCSI 6.77%PRS 23.83
-
CSI 3.34rCSI 7.97%PRS 17.01
-
CSI 3.34rCSI 2.7%PRS 14.17
-
CSI 3.33rCSI 12.97%PRS 23.39
-
CSI 3.32rCSI 2.58%PRS 20.61
-
CSI 3.31rCSI 4.5%PRS 34.03
-
CSI 3.3rCSI 2.64%PRS 25.85
-
CSI 3.25rCSI 2.44%PRS 40.4
-
CSI 3.21rCSI 9%PRS 22.09
-
CSI 3.21rCSI 4.77%PRS 17.39
-
CSI 3.2rCSI 20.97%PRS 36.56
-
CSI 3.14rCSI 5.94%PRS 30.93
-
CSI 2.99rCSI 2.08%PRS 20.3
-
CSI 2.93rCSI 53.68%PRS 41.02
-
CSI 2.88rCSI 15.73%PRS 23.84
-
CSI 2.83rCSI 2.73%PRS 10.04
-
CSI 2.82rCSI 2.34%PRS 14.34
-
CSI 2.82rCSI 5.66%PRS 10.6
-
CSI 2.79rCSI 16.71%PRS 22.67
-
CSI 2.77rCSI 3.17%PRS 29.28
-
CSI 2.76rCSI 7.76%PRS 20.25
-
CSI -5.1rCSI -9.7%PRS 32.8%
-
CSI -4.1rCSI -4.2%PRS 13.3%
-
CSI -4.0rCSI -5.5%PRS 15.9%
-
CSI -4.0rCSI -9.0%PRS 14.8%
-
CSI -2.7rCSI -4.4%PRS 22.7%
-
CSI -2.5rCSI -3.4%PRS 12.8%
-
CSI -2.1rCSI -11.3%PRS 25.6%
-
CSI -1.4rCSI -5.9%PRS 28.7%
-
CSI -1.1rCSI -0.8%PRS 19.5%
-
CSI -0.8rCSI -1.4%PRS 14.1%
-
CSI -0.8rCSI -12.7%PRS 52.0%
-
CSI -0.7rCSI -2.1%PRS 34.8%
-
CSI -0.6rCSI -3.5%PRS 18.7%
-
CSI -0.4rCSI -2.3%PRS 6.4%
-
CSI -0.4rCSI -3.7%PRS 39.2%
-
CSI -0.2rCSI -0.3%PRS 23.1%
-
CSI -0.1rCSI -0.2%PRS 14.4%
-
CSI 0.0rCSI 0.1%PRS 11.0%
-
CSI 0.0rCSI 0.6%PRS 53.5%
-
CSI 0.0rCSI 0.1%PRS 16.5%
-
CSI 0.0rCSI 0.1%PRS 24.2%
-
CSI 0.0rCSI 0.2%PRS 18.7%
-
CSI 0.1rCSI 1.0%PRS 44.8%
-
CSI 0.1rCSI 0.2%PRS 13.3%
-
CSI 0.1rCSI 0.1%PRS 10.5%
-
CSI 0.1rCSI 1.1%PRS 6.6%
-
CSI 0.1rCSI 0.3%PRS 23.0%
-
CSI 0.1rCSI 0.8%PRS 11.2%
-
CSI 0.1rCSI 1.9%PRS 62.6%
-
CSI 0.1rCSI 0.6%PRS 48.2%
-
CSI 0.1rCSI 0.5%PRS 50.5%
-
CSI 0.1rCSI 3.6%PRS 61.0%
-
CSI 0.2rCSI 1.7%PRS 35.4%
-
CSI 0.2rCSI 2.2%PRS 35.2%
-
CSI 0.2rCSI 2.4%PRS 35.1%
-
CSI 0.2rCSI 0.8%PRS 9.8%
-
CSI 0.2rCSI 0.7%PRS 19.9%
-
CSI 0.2rCSI 0.3%PRS 19.8%
-
CSI 0.2rCSI 0.3%PRS 23.2%
-
CSI 0.2rCSI 0.8%PRS 6.3%
-
CSI 0.2rCSI 1.0%PRS 50.2%
-
CSI 0.2rCSI 1.1%PRS 34.9%
-
CSI 0.2rCSI 0.8%PRS 29.3%
-
CSI 0.2rCSI 0.3%PRS 22.5%
-
CSI 0.2rCSI 0.8%PRS 24.6%
-
CSI 0.2rCSI 0.4%PRS 10.4%
-
CSI 0.2rCSI 2.7%PRS 14.7%
-
CSI 0.2rCSI 0.9%PRS 19.9%
-
CSI 0.2rCSI 0.3%PRS 24.7%
-
CSI 0.3rCSI 2.7%PRS 27.4%
-
CSI 0.3rCSI 0.4%PRS 15.1%
-
CSI 0.3rCSI 0.5%PRS 31.9%
-
CSI 0.3rCSI 1.6%PRS 21.5%
-
CSI 0.3rCSI 1.5%PRS 20.8%
-
CSI 0.3rCSI 0.4%PRS 13.3%
-
CSI 0.3rCSI 0.3%PRS 16.8%
-
CSI 0.3rCSI 4.9%PRS 65.3%
-
CSI 0.3rCSI 1.1%PRS 25.7%
-
CSI 0.3rCSI 0.5%PRS 16.7%
-
CSI 0.3rCSI 0.6%PRS 13.3%
-
CSI 0.3rCSI 1.1%PRS 52.2%
-
CSI 0.3rCSI 2.1%PRS 44.5%
-
CSI 0.3rCSI 3.1%PRS 55.6%
-
CSI 0.3rCSI 0.5%PRS 8.0%
-
CSI 0.4rCSI 1.6%PRS 14.1%
-
CSI 0.4rCSI 0.6%PRS 21.9%
-
CSI 0.4rCSI 0.4%PRS 15.0%
-
CSI 0.4rCSI 2.0%PRS 44.3%
-
CSI 0.4rCSI 0.9%PRS 19.7%
-
CSI 0.4rCSI 0.9%PRS 33.7%
-
CSI 0.4rCSI 0.7%PRS 28.0%
-
CSI 0.4rCSI 1.0%PRS 22.5%
-
CSI 0.4rCSI 2.3%PRS 37.6%
-
CSI 0.4rCSI 0.6%PRS 19.6%
-
CSI 0.4rCSI 3.0%PRS 30.1%
-
CSI 0.4rCSI 0.6%PRS 11.0%
-
CSI 0.4rCSI 3.0%PRS 26.1%
-
CSI 0.4rCSI 1.8%PRS 26.5%
-
CSI 0.4rCSI 0.5%PRS 15.6%
-
CSI 0.4rCSI 1.2%PRS 20.9%
-
CSI 0.4rCSI 0.7%PRS 12.2%
-
CSI 0.4rCSI 0.7%PRS 28.4%
-
CSI 0.4rCSI 0.3%PRS 25.3%
-
CSI 0.4rCSI 1.0%PRS 21.5%
-
CSI 0.4rCSI 0.5%PRS 16.9%
-
CSI 0.5rCSI 2.6%PRS 52.6%
-
CSI 0.5rCSI 1.1%PRS 13.2%
-
CSI 0.5rCSI 0.4%PRS 29.5%
-
CSI 0.5rCSI 0.5%PRS 15.3%
-
CSI 0.5rCSI 1.3%PRS 11.1%
-
CSI 0.5rCSI 1.8%PRS 3.2%
-
CSI 0.5rCSI 1.0%PRS 24.0%
-
CSI 0.5rCSI 2.7%PRS 21.9%
-
CSI 0.5rCSI 0.7%PRS 34.1%
-
CSI 0.5rCSI 0.7%PRS 16.5%
-
CSI 0.5rCSI 0.4%PRS 24.1%
-
CSI 0.5rCSI 0.4%PRS 21.6%
-
CSI 0.5rCSI 0.9%PRS 37.1%
-
CSI 0.5rCSI 1.8%PRS 23.4%
-
CSI 0.5rCSI 0.8%PRS 14.3%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 2429070281
Symbol: MYPT1_HUMAN
Name: Protein phosphatase 1 regulatory subunit 12A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 9286714
Title: Localization of the gene coding for myosin phosphatase, target subunit 1 (MYPT1) to human chromosome 12q15-q21.
PubMed ID: 9286714
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 16541075
Title: The finished DNA sequence of human chromosome 12.
PubMed ID: 16541075
DOI: 10.1038/nature04569
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 11342221
Title: Molecular cloning and analysis of the 5'-flanking region of human MYPT1 gene.
PubMed ID: 11342221
PubMed ID: 19245366
Title: MYPT1, the targeting subunit of smooth-muscle myosin phosphatase, is a substrate for the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH).
PubMed ID: 19245366
DOI: 10.1042/bj20081905
PubMed ID: 10567269
Title: Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha.
PubMed ID: 10567269
PubMed ID: 11287000
Title: Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity.
PubMed ID: 11287000
PubMed ID: 11067852
Title: Identification, characterization, and functional analysis of heart-specific myosin light chain phosphatase small subunit.
PubMed ID: 11067852
PubMed ID: 11331307
Title: Rho-kinase--mediated contraction of isolated stress fibers.
PubMed ID: 11331307
PubMed ID: 11283607
Title: Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing.
PubMed ID: 11283607
DOI: 10.1038/35070019
PubMed ID: 11719507
Title: Phosphorylation of the myosin-binding subunit of myosin phosphatase by Raf-1 and inhibition of phosphatase activity.
PubMed ID: 11719507
PubMed ID: 12873707
Title: Dimerization of cGMP-dependent protein kinase 1alpha and the myosin-binding subunit of myosin phosphatase: role of leucine zipper domains.
PubMed ID: 12873707
PubMed ID: 12923170
Title: PDZ domain-mediated interaction of interleukin-16 precursor proteins with myosin phosphatase targeting subunits.
PubMed ID: 12923170
PubMed ID: 12773565
Title: RhoE binds to ROCK I and inhibits downstream signaling.
PubMed ID: 12773565
PubMed ID: 15144186
Title: Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.
PubMed ID: 15144186
DOI: 10.1021/ac035352d
PubMed ID: 15194681
Title: Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695 in response to cyclic nucleotides.
PubMed ID: 15194681
PubMed ID: 15723050
Title: Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion.
PubMed ID: 15723050
DOI: 10.1038/ncb1230
PubMed ID: 17126281
Title: Novel ZIP kinase isoform lacks leucine zipper.
PubMed ID: 17126281
PubMed ID: 17081983
Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
PubMed ID: 17081983
PubMed ID: 16417406
Title: Hem-1 complexes are essential for Rac activation, actin polymerization, and myosin regulation during neutrophil chemotaxis.
PubMed ID: 16417406
PubMed ID: 17904578
Title: Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase.
PubMed ID: 17904578
PubMed ID: 18477460
Title: Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1.
PubMed ID: 18477460
PubMed ID: 18782776
Title: Probing the interaction between the coiled coil leucine zipper of cGMP-dependent protein kinase Ialpha and the C terminus of the myosin binding subunit of the myosin light chain phosphatase.
PubMed ID: 18782776
PubMed ID: 19367720
Title: Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.
PubMed ID: 19367720
DOI: 10.1021/pr800500r
PubMed ID: 18088087
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 19131646
Title: ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells.
PubMed ID: 19131646
PubMed ID: 19997641
Title: Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation.
PubMed ID: 19997641
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20354225
Title: New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion.
PubMed ID: 20354225
PubMed ID: 20634291
Title: Smoothelin-like 1 protein regulates myosin phosphatase-targeting subunit 1 expression during sexual development and pregnancy.
PubMed ID: 20634291
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 21457715
Title: Chelerythrine perturbs lamellar actomyosin filaments by selective inhibition of myotonic dystrophy kinase-related Cdc42-binding kinase.
PubMed ID: 21457715
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 22814378
Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
PubMed ID: 22814378
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 31883643
Title: Loss-of-function variants in PPP1R12A: from isolated sex reversal to holoprosencephaly spectrum and urogenital malformations.
PubMed ID: 31883643
PubMed ID: 19701943
Title: Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1.
PubMed ID: 19701943
DOI: 10.1002/prot.22529
Sequence Information:
- Length: 1030
- Mass: 115281
- Checksum: EA43E9BFF5DA08FF
- Sequence:
MKMADAKQKR NEQLKRWIGS ETDLEPPVVK RQKTKVKFDD GAVFLAACSS GDTDEVLKLL HRGADINYAN VDGLTALHQA CIDDNVDMVK FLVENGANIN QPDNEGWIPL HAAASCGYLD IAEFLIGQGA HVGAVNSEGD TPLDIAEEEA MEELLQNEVN RQGVDIEAAR KEEERIMLRD ARQWLNSGHI NDVRHAKSGG TALHVAAAKG YTEVLKLLIQ AGYDVNIKDY DGWTPLHAAA HWGKEEACRI LVDNLCDMEM VNKVGQTAFD VADEDILGYL EELQKKQNLL HSEKRDKKSP LIESTANMDN NQSQKTFKNK ETLIIEPEKN ASRIESLEQE KVDEEEEGKK DESSCSSEED EEDDSESEAE TDKTKPLASV TNANTSSTQA APVAVTTPTV SSGQATPTSP IKKFPTTATK ISPKEEERKD ESPATWRLGL RKTGSYGALA EITASKEGQK EKDTAGVTRS ASSPRLSSSL DNKEKEKDSK GTRLAYVAPT IPRRLASTSD IEEKENRDSS SLRTSSSYTR RKWEDDLKKN SSVNEGSTYH KSCSFGRRQD DLISSSVPST TSTPTVTSAA GLQKSLLSST STTTKITTGS SSAGTQSSTS NRLWAEDSTE KEKDSVPTAV TIPVAPTVVN AAASTTTLTT TTAGTVSSTT EVRERRRSYL TPVRDEESES QRKARSRQAR QSRRSTQGVT LTDLQEAEKT IGRSRSTRTR EQENEEKEKE EKEKQDKEKQ EEKKESETSR EDEYKQKYSR TYDETYQRYR PVSTSSSTTP SSSLSTMSSS LYASSQLNRP NSLVGITSAY SRGITKENER EGEKREEEKE GEDKSQPKSI RERRRPREKR RSTGVSFWTQ DSDENEQEQQ SDTEEGSNKK ETQTDSISRY ETSSTSAGDR YDSLLGRSGS YSYLEERKPY SSRLEKDDST DFKKLYEQIL AENEKLKAQL HDTNMELTDL KLQLEKATQR QERFADRSLL EMEKRERRAL ERRISEMEEE LKMLPDLKAD NQRLKDENGA LIRVISKLSK
Genular Protein ID: 1830357167
Symbol: B2RAH5_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Sequence Information:
- Length: 1030
- Mass: 115329
- Checksum: 5CA630A6EFF8C004
- Sequence:
MKMADAKQKR NEQLKRWIGS ETDLEPPVVK RQKTKVKFDD GAVFLAACSS GDTDEVLKLL HRGADINYAN VDGLTALHQA CIDDNVDMVK FLVENGANIN QPDNEGWIPL HAAASCGYLD IAEFLIGQGA HVGAVNSEGD TPLDIAEEEA MEELLQNEVN RQGVDIEAAR KEEERIMLRD ARQWLNSGHI NDVRHAKSGG TALHVAAAKG YTEVLKLLIQ AGYDVNIKDY DGWTPLHAAA HWGKEEACRI LVDNLCDMEM VNKVGQTAFD VADEDILGYL EELQKKQNLL HSEKRDKKSP LIESTANMDN NQSQKTFKNK ETLIIEPEKN ASRIESLEQE KVDEEEEGKK DESSCSSEED EEDDSESEAE TDKTKPLASV TNANTSSTQA APVAVTTPTV SSGQATPTSP IKKFPTTATK ISPKEEERKD ESPATWRLGL RKTGSYGALA EITASKEGQK EKDTAGVTRS ASSPRLSSSL DNKEKEKDSK GTRLAYVAPT IPRRLASTSD IEEKENRDSS SLRTSSSYTR RKWEDDLKKN SSVNEGSTYH KSCSFGRRQD DLISSSVPST TSTPTVTSAA GLQKSLLSST STTTKITTGS SSAGTQSSTS NRLWAEDSTE KEKDSVPTAV TIPVAPTVVN AAASTTTLTT TTAGTVSSTT EVRERRRSYL TPVRDEESES QRKARSRQAR QSRRSTQGVT LTDLQEAEKT IGRSRSTRTR EQENEEKEKE EKEKQDKEKQ EEKKESETSR EDEYKQKYSR TYDETYQRYR PVSTSSSTTP SSSLSTMSSS LYASSQLNRP NSLVGITSAY SRGITKENER EGEKREEEKE GEYKSQPKSI RERRRPREKR RSTGVSFWTQ DSDENEQEQQ SDTEEGSNKK ETQTDSISRY ETSSTSAGDR YDSLLGRSGS YSYLEERKPY SSRLEKDDST DFKKLYEQIL AENEKLKAQL HDTNMELTDL KLQLEKATQR QERFADRSLL EMEKRERRAL ERRISEMEEE LKMLPDLKAD NQRLKDENGA LIRVISKLSK